Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ants Toi

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
American Journal of Medical Genetics. Part A|November 14, 2008
Chondrodysplasia punctata associated with maternal autoimmune diseases: expanding the spectrum from systemic lupus erythematosus (SLE) to mixed connective tissue disease (MCTD) and scleroderma report of eight casesDavid Chitayat, Sarah Keating, Dina J Zand, et al.
European Radiology|May 4, 2022
Prostate biopsy in the era of MRI-targeting: towards a judicious use of additional systematic biopsyDominik Deniffel, Nathan Perlis, Sangeet Ghai, et al.
The Journal of Urology|December 8, 2014
Impact of the U.S. Preventive Services Task Force recommendations against prostate specific antigen screening on prostate biopsy and cancer detection ratesBimal Bhindi, Muhammad Mamdani, Girish S Kulkarni, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 2, 2005
A phase II study of localized prostate cancer treated to 75.6 Gy with 3D conformal radiotherapyAlan Nichol, Peter Chung, Gina Lockwood, et al.
International Journal of Radiation Oncology, Biology, Physics|January 31, 2012
Pathological predictors for site of local recurrence after radiotherapy for prostate cancerSupriya Chopra, Ants Toi, Nathan Taback, et al.
The Journal of Urology|June 5, 2020
Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?Dominik Deniffel, Emmanuel Salinas, Marc Ientilucci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
Variants of the hK2 protein gene (KLK2) are associated with serum hK2 levels and predict the presence of prostate cancer at biopsyRobert K Nam, William W Zhang, Laurence H Klotz, et al.
Urology|September 19, 2013
Obesity is associated with larger prostate volume but not with worse urinary symptoms: analysis of a large multiethnic cohortBimal Bhindi, David Margel, Greg Trottier, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 25, 2003
Comprehensive assessment of candidate genes and serological markers for the detection of prostate cancerRobert K Nam, William W Zhang, John Trachtenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2009
Utility of incorporating genetic variants for the early detection of prostate cancerRobert K Nam, William W Zhang, John Trachtenberg, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
American Journal of Medical Genetics. Part A|November 14, 2008
Chondrodysplasia punctata associated with maternal autoimmune diseases: expanding the spectrum from systemic lupus erythematosus (SLE) to mixed connective tissue disease (MCTD) and scleroderma report of eight casesDavid Chitayat, Sarah Keating, Dina J Zand, et al.
European Radiology|May 4, 2022
Prostate biopsy in the era of MRI-targeting: towards a judicious use of additional systematic biopsyDominik Deniffel, Nathan Perlis, Sangeet Ghai, et al.
The Journal of Urology|December 8, 2014
Impact of the U.S. Preventive Services Task Force recommendations against prostate specific antigen screening on prostate biopsy and cancer detection ratesBimal Bhindi, Muhammad Mamdani, Girish S Kulkarni, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 2, 2005
A phase II study of localized prostate cancer treated to 75.6 Gy with 3D conformal radiotherapyAlan Nichol, Peter Chung, Gina Lockwood, et al.
International Journal of Radiation Oncology, Biology, Physics|January 31, 2012
Pathological predictors for site of local recurrence after radiotherapy for prostate cancerSupriya Chopra, Ants Toi, Nathan Taback, et al.
The Journal of Urology|June 5, 2020
Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?Dominik Deniffel, Emmanuel Salinas, Marc Ientilucci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
Variants of the hK2 protein gene (KLK2) are associated with serum hK2 levels and predict the presence of prostate cancer at biopsyRobert K Nam, William W Zhang, Laurence H Klotz, et al.
Urology|September 19, 2013
Obesity is associated with larger prostate volume but not with worse urinary symptoms: analysis of a large multiethnic cohortBimal Bhindi, David Margel, Greg Trottier, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 25, 2003
Comprehensive assessment of candidate genes and serological markers for the detection of prostate cancerRobert K Nam, William W Zhang, John Trachtenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2009
Utility of incorporating genetic variants for the early detection of prostate cancerRobert K Nam, William W Zhang, John Trachtenberg, et al.
Pageof 11